SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body ... AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

Scientists see several important uses for staging. For example, it can steer people more precisely to appropriate treatments.

A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

A study involving over 1,700 participants from five hospitals across Barcelona, Sweden, and Italy has confirmed the ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

A new clinical trial has found that a common brain stimulation technique may help slow down cognitive and functional decline ...

Key takeaways Cholesterol regulation and neuronal vulnerability: The study found that neurons in the locus coeruleus (LC)—a ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study led by University College London (UCL) researchers.